(Boursier.com) — Implanet announces a turnover of 6 ME in
September 30, 2022, up +37%. The increase in turnover was driven by activity in France and in the rest of the world, experiencing growth of +40% and +73% respectively. This is a third consecutive quarter of revenue growth.
Ludovic Lastennet, Chief Executive Officer of Implanet, declared: “We achieved solid growth in the first nine months of 2022, both on our domestic market and also on export. This third quarter of growth has, moreover, opportunity to strengthen our position in the United States and to return to an annual rate of turnover of around 2 million euros in this strategic region.We also recently announced the success of our capital increase in the amount of 2.77 million euros, combined with an additional fundraising of 2.77 million euros due in Q1-2023, with the support of our partner Sanyou Medical. to deploy our range dedicated to spine surgery on the Chinese market while strengthening our investments in ‘R&D’ and securing our products at the regulatory level. rategic, we are confident in Implanet’s ability to reach a new milestone and achieve financial equilibrium in the medium term.”
Next financial press release: 2022 annual revenue, January 17, 2023 after market close.
©2022 Boursier.com